Investigator-Initiated, grant-supported pilot study evaluating a novel non-prescription therapy for…
Read More »
BioUtah will honor outstanding leaders in Utah’s life sciences community…
PhotoPharmics Surpasses Enrollment Target with 350 Participants in First-of-a-Kind Remote,…
The target lesion primary patency (TLPP)1 and access circuit primary…
Oxford Nanopore and bioMérieux launch AmPORE-TB, a Research Use Only…
Company forms new AI business unit, led by Chief Technology…
Health insurance costs are projected to rise sharply in 2026
Co-Diagnostics Forms New AI Business Unit and Expands Global Footprint…
Earning the first-ever SGS Cybersecurity Mark in the baby monitor…
The new Saudi-based CoMira Diagnostics joint venture will be engaged…
SAPIEN 3, which showed superiority at 1 year, also demonstrates…
ENCIRCLE mitral trial achieves primary and secondary endpoints.
DiscGenics and Collaborators Announce Breakthrough in Tissue-Engineered Intervertebral Disc Research
As part of Governor Spencer Cox’s Australia Trade Mission from…
Salt Lake City, Utah – October 21, 2025…
LEHI, Utah, Oct. 23, 2025 /PRNewswire/ — Halia Therapeutics, Inc., a…
SALT LAKE CITY, October 21, 2025— ARUP Laboratories today announced…
SALT LAKE CITY, Utah, Oct. 20, 2025 (GLOBE NEWSWIRE) —…
The Foresight® Carrier Screen includes all conditions recommended by the…
bioMérieux has just acquired a stake in Allergen Alert, an…
Notifications
